PCSK9 and bladder transitional cell carcinoma: According to the PFI analysis, high PCSK9 expression was correlated with poor prognoses in BLCA (P = 0.001), KIRC (P = 0.009), and thymoma (THYM) (P = 0.013) patients (Fig. 2C, Table S3).